Prescription drug · NDA
Pokonza (potassium chloride) NDC 15370-305
Potassium chloride .75 g/.79g · Powder, For solution · Oral · Carwin Pharmaceutical Associates, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 15370-305-04 | 15370030504 | 4 POUCH in 1 CARTON (15370-305-04) / .79 g in 1 POUCH (15370-305-01)Marketed from Sep 19, 2023 | |
| 15370-305-30 | 15370030530 | 30 POUCH in 1 CARTON (15370-305-30) / .79 g in 1 POUCH (15370-305-01)Marketed from Mar 18, 2024 | |
| 15370-305-60 | 15370030560 | 60 POUCH in 1 CARTON (15370-305-60) / .79 g in 1 POUCH (15370-305-01)Marketed from Sep 19, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pokonza
- Generic name (nonproprietary)
- potassium chloride
- Active ingredients
- Potassium chloride — .75 g/.79g
- Dosage form
- Powder, For solution
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208019
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 15370-305_4d2a603a-e0f8-43d4-a726-af60ffc6e744SPL ID 4d2a603a-e0f8-43d4-a726-af60ffc6e744SPL set ID 7c5cc705-e5da-4487-86c9-9d545a95afb4RxCUI 2665269, 2665275UNII 660YQ98I10
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N415370030504followed by a unit qualifier and the quantityPackage 15370-0305-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
POKONZA™ (Potassium Chloride for Oral Solution, USP) is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. POKONZA™ (Potassium Chloride for Oral Solution, USP) is a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 208019
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pokonzapotassium chloride | Potassium chloride 1.125 g/1.185g | Powder, For solutionOral | Carwin Pharmaceutical Associates, LLC | 15370-306 |
| Potassium Chloride | Potassium chloride 1.5 g/1.58g | Powder, For solutionOral | Endo USA, Inc. | 0603-1554 |
| Potassium Chloride | Potassium chloride 1.5 g/1.58g | Powder, For solutionOral | Genus Lifesciences Inc. | 64950-321 |
| Potassium Chloride | Potassium chloride 3 g/3.16g | For solutionOral | IPG Pharmaceuticals, Inc. | 71085-083 |